Healing Histories: Tracing the Medical Milestones of Blushwood

Healing Histories: Tracing the Medical Milestones of Blushwood

In the dense, tropical expanses of North Queensland’s Atherton Tablelands, nature has concealed a miraculous secret: a group of shrubs and trees that may revolutionize cancer treatment.

The Remarkable Discovery in the Atherton Tablelands

In this lush region near Cairns, plants belonging to the Fontainea family, notably Fontainea picrosperma, Hylandia dockrillii, and Fontainea venosa, commonly termed as Blushwood trees or shrubs, have been discovered to have potent anti-cancer properties. Remarkably, every part of these plants, from the flowers to the bark, contains a compound that can obliterate cancerous tumors in mere days without causing long-term side effects. Their efficacy against formidable solid tumors, such as those seen in melanoma, head, neck, and breast cancers, is promising.

However, the irony is sharp. These powerful shrubs and trees, which could provide a lifeline to countless individuals, are largely endangered. Their propagation is under the stringent control of the pharmaceutical realm, casting a shadow over their potential widespread use.

Marsupials Lead Scientists to a Breakthrough

The groundbreaking discovery came to light when Dr. Victoria Gordon and Dr. Paul Reddell from EcoBiotics, in 2006, noticed that local marsupials were reluctant to consume the seeds of Fontainea picrosperma due to an inflammatory chemical. This observation prompted them to further investigate, and soon they identified two standout compounds: EBC-46, with powerful anti-cancer attributes, and WH-1, known for exceptional wound healing qualities.

Astonishing Results with EBC-46

Under the expert guidance of Dr. Glen Boyle and his team at the QIMR Berghofer Medical Research Institute in Brisbane, the EBC-46 compound underwent rigorous testing. Results were nothing short of breathtaking. Upon applying EBC-46 to a lab mouse implanted with human skin cancer, the melanoma underwent drastic color changes before disintegrating completely.

Furthermore, the compound was experimented on various animals with dire prognoses. Many of these animals, spanning from dogs to the endangered Tasmanian devil, saw their melanoma tumors vanish post-treatment, establishing the compound's impressive potency.

How Does EBC-46 Work?

According to Dr. Boyle, EBC-46 operates by provoking a cellular reaction that effectively severs the tumor's blood supply. This not only halts the growth of the tumor but, in over 70% of preclinical cases, eradicated it. The results persisted with minimal relapse observed over a 12-month duration.

Beyond Cancer: The Wound Healing Miracle

The Blushwood shrubs' curative gifts don’t end with cancer. They also amplify the body's natural healing prowess. Dr. Gordon mentioned some astonishing instances where pet dogs, suffering from chronic, non-healing wounds, demonstrated significant recovery post-treatment with the new compound. Given the sizeable global demand for effective wound healing solutions, this discovery opens doors to potential applications in both human and veterinary medicine.

The Human Clinical Trials

The wonders of EBC-46 aren't restricted to the animal kingdom. Multi-centre human Clinical Phase I/II trials, initiated in 2015, are producing optimistic outcomes. Dr. Gordon disclosed that out of the eight patients treated so far, all have tolerated the drug without adverse effects. Additionally, each one showcased visible tumor breakdown, reflecting the same success seen in veterinary trials. Such universal efficacy points to EBC-46's potential to combat various tumors across different species.

One participant, Denise Powell, recounts her personal experience after receiving the EBC-46 injection for a tumor. In her words, "In less than 20 minutes, the tumor had gone purple then black. Then within a couple of days, the tumor just kind of shriveled up and died.” Such firsthand testimonies only serve to reinforce the potential life-changing properties of the Blushwood derivatives.

Responsible Cultivation: Ensuring Sustainability and Quality

The excitement surrounding the Blushwood berries and their life-saving potential has led to concerns about overharvesting from the wild, potentially pushing the plant closer to extinction. To ensure ethical and sustainable practices, it's crucial to underscore that we do not source our berries directly from the wild.

Instead, we have implemented a conscious choice to cultivate these invaluable berries in controlled indoor environments, predominantly located in Asia and Europe. These state-of-the-art facilities guarantee not only a consistent, year-round supply but also ensure that the berries' quality and potency are of the highest standard.

The benefits of such controlled cultivation are manifold:

  1. Protection of Natural Habitats: By not sourcing from the wild, we ensure that the native Blushwood population in the Atherton Tablelands remains undisturbed, safeguarding the plant's natural habitat and the ecosystem it supports.

  2. Consistency in Quality: Indoor cultivation eliminates the variables of weather and external pests, leading to a consistent yield of high-quality berries.

  3. Scalability: Indoor farming allows for increased production in response to global demand without impacting the wild Blushwood populations.

As we march forward in harnessing the Blushwood berries' power for the betterment of global health, our commitment remains unflinching – to ensure that this gift from nature is utilized responsibly, ethically, and sustainably. By merging the wonders of nature with the innovations of modern agriculture, we look forward to a brighter, healthier future for all.

In Closing

The journey from discovery to delivery is filled with obstacles, especially in the world of medicine. However, the discovery of the Blushwood shrubs' remarkable properties provides a beacon of hope for countless cancer patients worldwide. It serves as a testament to nature's boundless capabilities and emphasizes the need to preserve, study, and cherish our natural environment. As we stand on the brink of potentially game-changing medical advancements, it's imperative to ensure that the benefits of such discoveries are accessible to all and not just a select few.


Back to blog